News list for "China Inspection Medical"

The concept of cryptocurrency in Hong Kong stocks has expanded, and China Inspection Medical (01931.HK) has risen by more than 13% in the afternoon.

Hong Kong stocks crypto currency concept rose, China Inspection Medical (01931.HK) in the afternoon straight line rose more than 13%, Ouke Cloud Chain (01499.HK) rose more than 8%, Yunfeng Financial (00376.HK), Guotai Junan International (01788.HK), OLS Group (00863.HK) and other stocks rose. (Jin Ten)

clock
2025-11-10 05:59:28
Huajian Medical has started applying for a US stablecoin license and plans to raise funds to increase its US dollar reserves

Huajiao Medical (1931) announced the suspension of the planned cryptocurrency acquisition of no more than 3 billion yuan, and will disclose the Ethereum (ETH) transaction in the future according to the listing rules. At the same time, the 3.142 billion yuan transaction to acquire 20.31% of the equity of Guofu Quantum (0290) was cancelled. The company has adjusted its strategy, started to apply for a US stablecoin license and plans to raise funds to increase its US dollar reserves. Simultaneously...

clock
2025-11-03 00:48:58
Huajian Medical and Chuangsheng Group Sign 1.50 billion US Dollar Innovative Drug Pipeline Asset RWA Tokenization Strategic Cooperation Agreement

On September 22, the Hong Kong-listed company Huajian Medical announced that its company and its subsidiaries, ETHK Inc and ETHKHOLDINGSLIMITED, and Chuangsheng Group Pharmaceutical Co., Ltd. and its subsidiaries TranscentaOncologyInc. Signed a US $1.50 billion strategic cooperation agreement on potential innovative drug pipeline assets RWA tokenization related matters.

clock
2025-09-22 01:35:06
Huajian Medical and Renhe International have reached a cooperation to jointly build a vertical RWA trading platform focusing on the field of over-the-counter drugs

Hong Kong-listed company Huajian Medical announced that the group reached a strategic cooperation with Renhe International, an indirect wholly-owned subsidiary of Renhe Pharmaceutical, to jointly build a vertical RWA trading platform focusing on the field of over-the-counter drugs in the United States. (Zhitong Finance)

clock
2025-09-16 04:56:53
China Inspection Medical plans to spend no more than 3 billion Hong Kong dollars to buy cryptocurrency

China Inspection Medical (01931.HK) announced that as the board of directors believes that the purchase and holding of cryptocurrencies is an important measure for the group to consolidate the Ethereum (ETH) reserve treasury and accelerate the construction of the ivd.xyz exchange ecosystem, and is also an important part of the group's asset allocation strategy, after careful consideration, the board of directors recommends seeking the prior approval of shareholders to grant the purchase authoriz...

clock
2025-08-15 11:00:19
Huajian Medical officially launched the Ethereum treasury strategy

According to aastocks, Huajian Medical (stock code 01931) announced that it has officially launched the "Global Enhanced Ethereum Treasury with Downside Protection Mechanism" strategy. Based on the needs of strategic layout, Ethereum is used as the core reserve asset, and the goal is to become the leading listed company in the Hong Kong stock market and even the global Ethereum reserve scale. The Group will use equity funds, stable annual distributable profits, existing inefficient inventory ass...

clock
2025-08-10 12:52:04
Hong Kong-listed company Huajian Medical (01931.HK) launched IVDD stablecoin and created "IVDNewCo Exchange" ecosystem

On July 18, according to the official information disclosure system of the Hong Kong Stock Exchange, Huajiao Medical (01931.HK) announced the official launch of the "IVDNewCo Exchange" ecological plan, launching the world's first RWA exchange ecosystem focusing on medical innovative drugs NewCo high-tech assets and supporting the issuance of IVDD stablecoin plan. Huajian Medical is actively promoting a landmark strategic initiative to build a "New...

clock
2025-07-18 05:13:34
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.